Iradimed Co - Asset Resilience Ratio

Latest as of December 2022: 0.00%

Iradimed Co (IRMD) has an Asset Resilience Ratio of 0.00% as of December 2022. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read total liabilities of Iradimed Co for a breakdown of total debt and financial obligations.

Liquid Assets

$0.00
Cash + Short-term Investments

Total Assets

$85.51 Million
All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2012–2022)

This chart shows how Iradimed Co's Asset Resilience Ratio has changed over time. See IRMD net assets for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Iradimed Co's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Iradimed Co market cap and net worth.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents $0.00 0%
Short-term Investments $0.00 0%
Total Liquid Assets $0.00 0.00%

Asset Resilience Insights

  • Limited Liquidity: Iradimed Co maintains only 0.00% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company maintains a balanced mix of cash and short-term investments.

Iradimed Co Industry Peers by Asset Resilience Ratio

Compare Iradimed Co's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
INKON Life Technology Co Ltd
SHE:300143
Medical Devices 3.37%
CareRay Digital Medical Technology Co Ltd
SHG:688607
Medical Devices 16.21%
Senseonics Holdings, Inc. Common Stock
NYSE MKT:SENS
Medical Devices 54.67%
Universus Photo Imagings Limited
NSE:UNIVPHOTO
Medical Devices 30.97%
HansBiomed Corporation
KQ:042520
Medical Devices 9.13%
Aligned Genetics Inc
KQ:238120
Medical Devices 2.22%
Heramed Ltd
AU:HMD
Medical Devices 0.83%
Acarix A/S
ST:ACARIX
Medical Devices 37.81%

Annual Asset Resilience Ratio for Iradimed Co (2012–2022)

The table below shows the annual Asset Resilience Ratio data for Iradimed Co.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2022-12-31 0.00% $0.00 $85.51 Million --
2021-12-31 0.61% $501.86K $82.88 Million -2.08pp
2020-12-31 2.69% $1.91 Million $71.07 Million -1.46pp
2019-12-31 4.15% $2.77 Million $66.73 Million -8.96pp
2018-12-31 13.11% $6.35 Million $48.44 Million -7.74pp
2017-12-31 20.85% $8.14 Million $39.01 Million -0.56pp
2016-12-31 21.42% $7.97 Million $37.19 Million -0.15pp
2015-12-31 21.57% $7.60 Million $35.24 Million -12.38pp
2014-12-31 33.95% $7.91 Million $23.31 Million +30.43pp
2013-12-31 3.52% $246.20K $6.99 Million -0.99pp
2012-12-31 4.52% $250.79K $5.55 Million --
pp = percentage points

About Iradimed Co

NASDAQ:IRMD USA Medical Devices
Market Cap
$1.11 Billion
Market Cap Rank
#8676 Global
#2341 in USA
Share Price
$87.15
Change (1 day)
+4.45%
52-Week Range
$51.01 - $105.15
All Time High
$105.15
About

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices and related accessories, and disposables and services in the United States and internationally. The company offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; MRI compatible patient vital signs monitoring syst… Read more